2. QUALITATIVE AND QUANTITATIVE …
Internal document code 1 max040418iNZ . NEW ZEALAND DATA SHEET . 1. PRODUCT NAME . MaxidexTM (dexamethasone) 0.1% sterile ophthalmic suspension and ointment.. 2. QUALITATIVE AND QUANTITATIVE
Download 2. QUALITATIVE AND QUANTITATIVE …
Information
Domain:
Source:
Link to this page:
Documents from same domain
ADVANTAN Presentation Uses - Medsafe
www.medsafe.govt.nzADVANTAN® Data Sheet Page 1 of 9 ADVANTAN® Methylprednisolone aceponate 0.1% ointment/cream . Presentation 1 g cream or ointment contains 1 mg (0.1%) methylprednisolone aceponate.
LOXALATE 1. Product Name - Medsafe Home Page
www.medsafe.govt.nzPage 5of 21 at risk, such as the elderly, or patients with cirrhosis, or if used in combination with other medications which may cause hyponatraemia.
DATA SHEET 1 CLEXANE AND CLEXANE FORTE ... - …
www.medsafe.govt.nzNew Zealand Data Sheet June 2017 . clexane-clexane-forte-ccdsv13-dsv18-16jun17 Page 2 . 100 mg injection enoxaparin sodium 100mg (equivalent to …
SEPTANEST Articaine hydrochloride 4% with …
www.medsafe.govt.nzSEPTANEST Articaine hydrochloride 4% with adrenaline 1:100,000 Injection for local and regional dental anaesthesia DESCRIPTION SEPTANEST is a sterile aqueous solution that contains articaine hydrochloride 4% (40 mg/mL) with adrenaline acid tartrate in a 1:100,000 strength.
BOOSTRIX - Medsafe Home Page
www.medsafe.govt.nz1 BOOSTRIX®. Combined diphtheria, tetanus, acellular pertussis (dTpa) vaccine . CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET? This leaflet answers some of the common questions about BOOSTRIX vaccine.
NEW ZEALAND DATA SHEET - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET Cymevene ® DS 170831 2 of 26 Caution: Cymevene must only be administered by IV infusion over 1 hour, preferably via a
Edition Draft - Medsafe
www.medsafe.govt.nzPart 4, Ed Draft Page 2 of 9 Section 1: Good Manufacturing Practice Documentation 1.1. When is GMP Documentation Required? Medsafe requires evidence of Good Manufacturing Practice (GMP) compliance for
Data Sheet 1 PRODUCT NAME 2 QUALITATIVE AND …
www.medsafe.govt.nzNew Zealand Data Sheet 31 July 2017 Lantus – insulin glargine lantus-ccdsv19-dsv11-31jul17 Page 1 Data Sheet 1 PRODUCT NAME Lantus 100 IU/mL solution for injection in 10 …
NEW ZEALAND DATA SHEET MESTINON® - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET MESTINON® MESTINON Page 4 of 8 As the severity of myasthenia gravis often fluctuates considerably, particular care is required to
DATA SHEET PREDNISONE - Medsafe
www.medsafe.govt.nz• Epilepsy and/or seizure disorder • Peptic ulceration • Previous steroid myopathy • Tuberculosis • Patients with myasthenia gravis receiving anticholinesterase therapy since
Related documents
SUMMARY OF PRODUCT CHARACTERISTICS 1 …
www.sanofi-aventis.co.ukSUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Targocid 200mg Teicoplanin 200mg Powder for Injection Targocid 400mg Teicoplanin 400mg Powder for Injection
2. QUALITATIVE AND QUANTITATIVE COMPOSITION
www.baxter.inOliClinomel N4-550E: The maximum daily dose is 40ml/kg body weight (equivalent to 0.88 g of amino-acids, 3.2 g of glucose and 0.8 g of lipids per kg), i.e. 2,800 ml …
Section 2: Qualitative and quantitative composition
www.ema.europa.euI. General objectives of section 2 3 Section 2: Qualitative and quantitative composition Excipients listed in the Annex to the “Guideline on the excipients in the label and package leaflet of medicinal product for human use”
AUSTRALIAN PRODUCT INFORMATION PANADOL …
www.medicines.org.au4 PANADOL CHILDREN 1 to 5 YEARS COLOURFREE SUSPENSION AGE AVERAGE WEIGHT DOSE 1 – 2 years 10 - 12 kg 6 - 8 mL 2 – 3 years 12 - 14 kg 8 - 9 mL
AUSTRALIAN PRODUCT INFORMATION PANADOL …
www.medicines.org.au1 australian product information panadol osteo (paracetamol) tablets 1 name of the medicine paracetamol 2 qualitative and quantitative composition
2. QUALITATIVE AND QUANTITATIVE …
www.medsafe.govt.nzInternal document code 1 Cyc11 0418iNZ NEW ZEALAND DATA SHEET 1. PRODUCT NAME CYCLOGYLTM (cyclopentolate hydrochloride) Eye Drops 1.0% 2. QUALITATIVE AND QUANTITATIVE COMPOSITION